https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/frances-sanofi-to-buy-u-s-drugs-project-inbrx-101-for-about-2-2-bln/107085306
France's Sanofi to buy U.S. drugs project INBRX-101 for about $2.2 bln, ETHealthworld
Sanofi: The two companies said in a joint statement on Tuesday that Inhibrx shareholders will get $30 per share in cash, one contingent value right (CVR) equal...